Cloning of B cell lymphoma-associated antigens using modified phage-displayed expression cDNA library and immunized patient sera

Journal of Immunological Methods

Volumn 312, Issue 1-2, 2006, Pages 79-93

  Cha, Soung Chul ^a   Kwak, Larry W ^a   Ruffini, Pier Adelchi ^b   Qin, Hong ^a   Neelapu, Sattva ^a   Biragyn, Arya ^c  

^a Center for Cancer Immunology Research   (United States)

^b OSPEDALE NIGUARDA CA GRANDA   (Italy)

^c NATIONAL INSTITUTE ON AGING   (United States)

Author keywords

B cell lymphoma; Epitope spreading; Phage display; Tumor antigen discovery

Indexed keywords

AUTOANTIGEN; COMPLEMENTARY DNA; EPITOPE; GLUTAMINYLLYSYLGLUTAMINYLGLUTAMINYLLEUCYLLYSYLGLUTAMINYLPROLYLPROLYL TRYPTOPHANYLARGINYLLYSYLPROLYLGLUTAMYLASPARAGINYLSERYLTHREONYLCYSTEINYLSERYL ARGINYLGLUTAMYLGLYCYLLEUCYLVALYLARGINYLALANINE; GLYCYLGLUTAMINYLARGINYLGLUTAMINYLPROLYLARGINYLHISTIDYLVALYLHISTIDYLGLYCYL VALINE; GUANOSINE TRIPHOSPHATASE; IMMUNOGLOBULIN IDIOTYPE; PEPTIDE; TUMOR ANTIGEN; UNCLASSIFIED DRUG; VACCINE;

5' UNTRANSLATED REGION; AMINO ACID SEQUENCE; ARTICLE; B CELL LYMPHOMA; CLINICAL ARTICLE; CONTROLLED STUDY; DNA LIBRARY; GENE EXPRESSION; HUMAN; HUMAN CELL; HUMAN TISSUE; IMMUNE RESPONSE; IMMUNIZATION; MOLECULAR CLONING; NUCLEOTIDE SEQUENCE; OPEN READING FRAME; PHAGE DISPLAY; PRIORITY JOURNAL; RECOMBINANT GENE; SCREENING; SEROLOGY; SERUM; TUMOR CELL; VACCINATION;

AMINO ACID SEQUENCE; ANTIBODIES, NEOPLASM; ANTIGENS, NEOPLASM; CANCER VACCINES; CLONING, MOLECULAR; DNA, COMPLEMENTARY; GENE LIBRARY; GTP-BINDING PROTEINS; HUMANS; IMMUNE SERA; IMMUNOGLOBULIN IDIOTYPES; LYMPHOMA, B-CELL; LYMPHOMA, FOLLICULAR; MOLECULAR SEQUENCE DATA; PEPTIDE LIBRARY; PEPTIDES; RIBONUCLEOPROTEIN, U1 SMALL NUCLEAR;

EID: 33646910521     PISSN: 00221759     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jim.2006.02.013     Document Type: Article

References (25)

1. Bendandi M., Gocke C.D., Kobrin C.B., Benko F.A., Sternas L.A., Pennington R., Watson T.M., Reynolds C.W., Gause B.L., Duffey P.L., Jaffe E.S., Creekmore S.P., Longo D.L., and Kwak L.W. Complete molecular remissions induced by patient-specific vaccination plus granulocyte-monocyte colony-stimulating factor against lymphoma. Nat. Med. 5 (1999) 1171
2. Brandle D., Brasseur F., Weynants P., Boon T., and Van den Eynde B. A mutated HLA-A2 molecule recognized by autologous cytotoxic T lymphocytes on a human renal cell carcinoma. J. Exp. Med. 183 (1996) 2501
3. Brichard V., Van Pel A., Wolfel T., Wolfel C., De Plaen E., Lethe B., Coulie P., and Boon T. The tyrosinase gene codes for an antigen recognized by autologous cytolytic T lymphocytes on HLA-A2 melanomas. J. Exp. Med. 178 (1993) 489
4. Butterfield L.H., Ribas A., Dissette V.B., Amarnani S.N., Vu H.T., Oseguera D., Wang H.J., Elashoff R.M., McBride W.H., Mukherji B., Cochran A.J., Glaspy J.A., and Economou J.S. Determinant spreading associated with clinical response in dendritic cell-based immunotherapy for malignant melanoma. Clin. Cancer Res. 9 (2003) 998
5. Chen Y.T., Scanlan M.J., Sahin U., Tureci O., Gure A.O., Tsang S., Williamson B., Stockert E., Pfreundschuh M., and Old L.J. A testicular antigen aberrantly expressed in human cancers detected by autologous antibody screening. Proc. Natl. Acad. Sci. U. S. A. 94 (1997) 1914
6. Disis M.L., Goodell V., Schiffman K., and Knutson K.L. Humoral epitope-spreading following immunization with a her-2/neu peptide based vaccine in cancer patients. J. Clin. Immunol. 24 (2004) 571
7. Dohner K., Brown J., Hehmann U., Hetzel C., Stewart J., Lowther G., Scholl C., Frohling S., Cuneo A., Tsui L.C., Lichter P., Scherer S.W., and Dohner H. Molecular cytogenetic characterization of a critical region in bands 7q35-q36 commonly deleted in malignant myeloid disorders. Blood 92 (1998) 4031
8. Huang S., Preuss K.D., Xie X., Regitz E., and Pfreundschuh M. Analysis of the antibody repertoire of lymphoma patients. Cancer Immunol. Immunother. 51 (2002) 655
9. Jager E., Chen Y.T., Drijfhout J.W., Karbach J., Ringhoffer M., Jager D., Arand M., Wada H., Noguchi Y., Stockert E., Old L.J., and Knuth A. Simultaneous humoral and cellular immune response against cancer-testis antigen NY-ESO-1: definition of human histocompatibility leukocyte antigen (HLA)-A2-binding peptide epitopes. J. Exp. Med. 187 (1998) 265
10. Kao H., Marto J.A., Hoffmann T.K., Shabanowitz J., Finkelstein S.D., Whiteside T.L., Hunt D.F., and Finn O.J. Identification of cyclin B1 as a shared human epithelial tumor-associated antigen recognized by T cells. J. Exp. Med. 194 (2001) 1313
11. Krucken J., Schroetel R.M., Muller I.U., Saidani N., Marinovski P., Benten W.P., Stamm O., and Wunderlich F. Comparative analysis of the human GIMAP gene cluster encoding a novel GTPase family. Gene 341 (2004) 291
12. Mandruzzato S., Brasseur F., Andry G., Boon T., and van der Bruggen P. A CASP-8 mutation recognized by cytolytic T lymphocytes on a human head and neck carcinoma. J. Exp. Med. 186 (1997) 785
13. Mintz P.J., Kim J., Do K.A., Wang X., Zinner R.G., Cristofanilli M., Arap M.A., Hong W.K., Troncoso P., Logothetis C.J., Pasqualini R., and Arap W. Fingerprinting the circulating repertoire of antibodies from cancer patients. Nat Biotechnol. 21 (2003) 57
14. Prezzi C., Nuzzo M., Meola A., Delmastro P., Galfre G., Cortese R., Nicosia A., and Monaci P. Selection of antigenic and immunogenic mimics of hepatitis C virus using sera from patients. J. Immunol. 156 (1996) 4504
15. Rosenberg S.A. Progress in the development of immunotherapy for the treatment of patients with cancer. J. Intern. Med. 250 (2001) 462
16. Sahin U., Tureci O., Schmitt H., Cochlovius B., Johannes T., Schmits R., Stenner F., Luo G., Schobert I., and Pfreundschuh M. Human neoplasms elicit multiple specific immune responses in the autologous host. Proc. Natl. Acad. Sci. U. S. A. 92 (1995) 11810
17. St Clair E.W., Query C.C., Bentley R., Keene J.D., Polisson R.P., Allen N.B., Caldwell D.S., Rice J.R., Cox C., and Pisetsky D.S. Expression of autoantibodies to recombinant (U1) RNP-associated 70K antigen in systemic lupus erythematosus. Clin Immunol. Immunopathol. 54 (1990) 266
18. Theissen H., Etzerodt M., Reuter R., Schneider C., Lottspeich F., Argos P., Luhrmann R., and Philipson L. Cloning of the human cDNA for the U1 RNA-associated 70K protein. Embo J. 5 (1986) 3209
19. Tolpin M.D., Starr S.E., Arbeter A.M., and Plotkin S.A. Inactivated mouse cytomegalovirus vaccine: preparation, immunogenicity, and protective effect. J. Infect. Dis. 142 (1980) 569
20. Tsui P., Tornetta M.A., Ames R.S., Silverman C., Porter T., Weston C., Griego S., and Sweet R.W. Progressive epitope-blocked panning of a phage library for isolation of human RSV antibodies. J. Immunol. Methods 263 (2002) 123
21. Wang R.F. The role of MHC class II-restricted tumor antigens and CD4+ T cells in antitumor immunity. Trends Immunol 22 (2001) 269
22. Wang R.F., Wang X., and Rosenberg S.A. Identification of a novel major histocompatibility complex class II-restricted tumor antigen resulting from a chromosomal rearrangement recognized by CD4(+) T cells. J. Exp. Med. 189 (1999) 1659
23. Wang X., Yu J., Sreekumar A., Varambally S., Shen R., Giacherio D., Mehra R., Montie J.E., Pienta K.J., Sanda M.G., Kantoff P.W., Rubin M.A., Wei J.T., Ghosh D., and Chinnaiyan A.M. Autoantibody signatures in prostate cancer. N. Engl. J. Med. 353 (2005) 1224
24. Wolfgang C.D., Essand M., Vincent J.J., Lee B., and Pastan I. TARP: a nuclear protein expressed in prostate and breast cancer cells derived from an alternate reading frame of the T cell receptor gamma chain locus. Proc. Natl. Acad. Sci. U. S. A. 97 (2000) 9437
25. Xie X., Wacker H.H., Huang S., Regitz E., Preuss K.D., Romeike B., Parwaresch R., Tiemann M., and Pfreundschuh M. Differential expression of cancer testis genes in histological subtypes of non-Hodgkin's lymphomas. Clin. Cancer Res. 9 (2003) 167